Richard Peters
Chairman at APREA THERAPEUTICS, INC.
Net worth: 39 336 $ as of 2024-04-29
Richard Peters active positions
| Companies | Position | Start | End |
|---|---|---|---|
| APREA THERAPEUTICS, INC. | Independent Dir/Board Member | 2020-06-29 | - |
| Chairman | 2023-08-22 | - | |
| Director/Board Member | 2020-06-29 | 2023-08-22 | |
| KINETA, INC. | Director/Board Member | 2022-12-18 | - |
| Independent Dir/Board Member | 2022-12-18 | - | |
| PHARMING GROUP N.V. | Chairman | 2023-09-24 | - |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| President | - | - | |
Tellbio, Inc.
 Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | Chairman | - | - |
| Founder | - | - |
Career history of Richard Peters
Former positions of Richard Peters
| Companies | Position | Start | End |
|---|---|---|---|
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Director/Board Member | 2016-02-29 | 2022-05-31 |
| Founder | 2016-02-29 | 2022-05-31 | |
| YUMANITY THERAPEUTICS | Director/Board Member | 2020-12-22 | 2021-12-31 |
| Chief Executive Officer | 2020-12-22 | 2021-12-31 | |
| President | 2020-12-22 | 2021-12-31 | |
| Corporate Secretary | 2020-12-22 | 2021-12-31 | |
| Treasurer | 2020-12-22 | 2021-12-31 | |
| MERRIMACK PHARMACEUTICALS, INC. | Director/Board Member | 2017-02-05 | 2019-06-27 |
| Chief Executive Officer | 2017-02-05 | 2019-06-27 | |
| Director of Finance/CFO | 2017-06-13 | 2017-08-20 | |
| President | 2017-02-05 | 2019-06-27 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2007-12-31 | 2016-12-31 |
| ░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
Training of Richard Peters
| Medical University of South Carolina | Doctorate Degree |
| College of Charleston | Undergraduate Degree |
Statistics
International
| United States | 15 |
| 2 | |
| Netherlands | 2 |
Operational
| Director/Board Member | 7 |
| Founder | 5 |
| Chief Executive Officer | 4 |
Sectoral
| Health Technology | 13 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
| PHARMING GROUP N.V. | Health Technology |
| Private companies | 9 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
MedNav, Inc.
 MedNav, Inc. Packaged SoftwareTechnology Services MedNav, Inc. develops mobile health applications. | Technology Services |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Health Technology |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Health Technology |
Tellbio, Inc.
Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
| Kineta, Inc. |
- Stock Market
- Insiders
- Richard Peters
- Experience